Gastrointestinal

LECTURES & BREAKOUTS Tuesday, February 15, 2000
Time	Title	Speaker

8:00 am	Welcome and Introduction	Michael J. O'Connell, MD
8:00 am	Welcome and Introduction	Robert J. Mayer, MD

8:15	Present Status
	Pathogenesis	Eric R. Fearon, MD, PhD
	Markers	Stanley R. Hamilton, MD
	Therapy	Michael J. O'Connell, MD

9:15	Is There Life Beyond Histochemical Staging?	Carolyn C. Compton, MD, PhD
		Daniel J. Sargent, PhD
		Robert S. Warren, MD

10:00	Discussion

11:00	What Are the Most Promising Novel Targets for Therapy?	Charles Erlichman, MD
		Alex A. Adjei, MD, PhD
		Kenneth A. Foon, MD
		Lee M. Ellis, MD

11:45	Discussion

1:30 pm	What Model in Clinical Design Should We Use to Examine New Cytostatic Compounds?	Neal J. Meropol, MD
		Elizabeth Eisenhauer, MD
		Edward L. Korn, PhD

2:15	Discussion

3:00	Are There Unanswered Questions Remaining in Surgical Management?	Nicholas J. Petrelli, MD
		Margaret Kemeny, MD
		Norman Wolmark, MD

3:45	Discussion

4:45	Can New Imaging Technologies Influence Therapy?	John M. Hoffman, MD
		Pablo R. Ros, MD, MPH
		Michael M. Graham, MD, PhD
		Eric vanSonnenberg, MD

5:30	Discussion

6:15	Adjourn

Wednesday, February 16, 2000
Time	Title	Speaker

8:00 am	Can Treatment Be Tailored to Biologic Characteristics?	James L. Abbruzzese, MD
		Peter V. Danenberg, PhD
		Leonard B. Saltz, MD
		Al B. Benson, III, MD

8:45	Discussion




9:30	Why Does Treatment Fail?	Joel E. Tepper, MD
		Carmen J. Allegra , MD
		Ian F. Tannock, MD
		W. Gillies McKenna, MD, PhD

10:15	Discussion

11:00	Summary	Robert J. Mayer, MD

11:30 am	Adjourn